Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Baxter
AstraZeneca
Merck
Moodys

Last Updated: January 27, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for XP19986


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug XP19986?

XP19986 is an investigational drug.

There have been 6 clinical trials for XP19986. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2011.

The most common disease conditions in clinical trials are Gastroesophageal Reflux, Muscle Spasticity, and Sclerosis. The leading clinical trial sponsors are Indivior Inc., XenoPort, Inc., and [disabled in preview].

Recent Clinical Trials for XP19986
TitleSponsorPhase
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple SclerosisIndivior Inc.Phase 3
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple SclerosisXenoPort, Inc.Phase 3
A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD)Indivior Inc.Phase 2

See all XP19986 clinical trials

Clinical Trial Summary for XP19986

Top disease conditions for XP19986
Top clinical trial sponsors for XP19986

See all XP19986 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Baxter
AstraZeneca
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.